Since the CNBC Investing Club’s July Monthly Meeting, the stock market has seesawed up and then down on a slew of quarterly earnings results and inflation data. That’s left Wall Street struggling this month. Here’s a look at the best performers from the Club’s 36 holdings from the market close after the July 12 meeting through Wednesday, the last full session before Thursday’s August Monthly Meeting. 1. Eli Lilly Eli Lilly and Company (LLY) is the major winner of our portfolio, surging 23.97% over the period. The health-care name posted a strong quarterly report on Aug. 8, sending shares to an all-time high. Eli Lilly easily topped Wall Street estimates on earnings and sales, adding over $60 billion of market value in a day and even more since. Mounjaro, the diabetes treatment that may soon be approved by regulators for weight loss as well, is contributing to Lilly’s multiyear positive outlook. Jim Cramer has predicted that Mounjaro will be ” the best-selling drug of all time .” LLY was down less than 1% during Thursday trading at $544. Still, the company is up 48% year-to-date. LLY mountain 2023-08-16 Eli Lilly (LLY) performance 2. Humana Humana (HUM) is up 16.36% since the July meeting, the Club’s second-best performing name over the roughly five-week period. The health insurer soared earlier this month after reporting second-quarter numbers that beat expectations . Management commentary assuaged concerns over medical-cost trends that previously soured HUM’s share price. Jim said during the August Monthly Meeting on Thursday that he’s not as enamored with this stock recently. HUM was trading at $490 a share, down nearly 1% on Thursday. HUM has tumbled more than 4% year-to-date. HUM mountain 2023-08-16 Humana (HUM) performance 3. Pioneer Natural Resources Pioneer Natural Resources (PXD) shot up 8.44%. Shares surged after a hearty quarterly earnings beat on Aug. 1, when the company revealed it weathered the three-month period well despite oil prices that were…
Read the full article here
Leave a Reply